Support The Moscow Times!

France Slams Russia's Sputnik Vaccine as 'Propaganda' Tool

French Foreign Minister Jean-Yves Le Drian said Russia was using its vaccine to gain influence abroad before vaccinating its own population. Sergei Vedyashkin / Moskva News Agency

France on Friday accused Russia of using its Sputnik V Covid-19 vaccine as a tool to spread Moscow's influence and message rather than as way to fight the global health crisis.

"In terms of how it is managed, it (the Sputnik V vaccine) is more a means of propaganda and aggressive diplomacy than a means of solidarity and health aid," Foreign Minister Jean-Yves Le Drian told France Info radio. 

The Russian vaccine has come under much criticism in Western countries, while President Vladimir Putin — who got a Sputnik jab himself on Tuesday — has dismissed the skepticism as "strange."

Le Drian said both Russia and China were using their vaccines to gain influence abroad "even before vaccinating their own populations."

The minister said Russia had announced "with a lot of media attention" that it would deliver 30,000 vaccine doses to Tunisia.

But the UN-backed Covax initiative had already delivered 100,000 doses to the north African country, with 400,000 more to come by May, he said.

"That is what real solidarity work looks like, that is true health cooperation," Le Drian said.

The Kremlin rejected Friday that Russia and China were using their vaccines as tools to win geopolitical clout.

"We absolutely disagree with the fact that both Russia and China are waging some kind of war," Kremlin spokesman Dmitry Peskov told journalists. 

"And we absolutely disagree with the fact that Russia and China are using the coronavirus pandemic and vaccines as tools of influence," he added.

Russia registered Sputnik V in August, ahead of large-scale clinical trials, prompting worries among many experts over the fast-track process.

Later reviews have been largely positive, with leading medical journal The Lancet publishing results showing it is safe and more than 90% effective.

The European Medicines Agency this month launched a rolling review of Sputnik V, a key step towards it being approved as the first non-Western coronavirus jab to be used across the 27-nation bloc.

Sign up for our free weekly newsletter

Our weekly newsletter contains a hand-picked selection of news, features, analysis and more from The Moscow Times. You will receive it in your mailbox every Friday. Never miss the latest news from Russia. Preview
Subscribers agree to the Privacy Policy

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more